The company's products are designed to help with the surgical treatment of bone, cartilage, and other human tissue diseases, using bio-compatible and naturally-derived materials to promote faster tissue regeneration. SurgaColl Technologies aims to become a leader in the field of regenerative medical devices, based on technology developed by the Tissue Engineering Research Group at the Royal College of Surgeons in Ireland. Their products facilitate the body's own natural healing processes, allowing patients to safely and quickly return to a healthy and active lifestyle.